Merck Sharp & Dohme
2000 Galloping Hill Road
59 articles with Merck Sharp & Dohme
The agreement with Merck brings $290 million upfront to Orion to access the latter's investigational candidate, ODM-208, for mCPRC and other related drugs.
Symvivo Corporation Announces Collaboration with Merck
Symvivo Corporation, a clinical-stage biotechnology company advancing a proprietary bacTRL™ gene delivery platform, announced today that it has entered into a research collaboration with Merck Sharp and Dohme Corp. Under the terms of the agreement, Merck receives an option to take an exclusive license to Symvivo’s bacTRL™ platform technology for use in advancing delivery of oral vaccines. “We are excited to
More job cuts are coming to California life science companies. Charles River Labs and Janssen are both making cuts as they reprioritize their businesses, according to Worker Adjustment and Retraining Notifications filed with the state of California.
January was a rough month for many pharma employees in California, as several companies pulled the trigger on layoffs, or announced coming layoffs that will affect hundreds of employees.
According to BioPharm Catalyst there were, or soon will be, 58 biopharma IPOs in 2018. And the trend doesn’t appear to be slowing. Here’s a look at five upcoming biotech IPOs.
Urovant Sciences, a Vivek Ramaswamy company under the Roivant umbrella, has filed for an initial public offering (IPO) to raise $150 million. It will list on Nasdaq under the UROV symbol.
Riffyn Forms Advisory Board of Biopharm and Biotech R&D Innovators
Mr. Falholt previously served as the head of Novozymes R&D. Mr. Deshmukh most recently served as the Executive Director of R&D IT at Merck Sharp & Dohme.
Layoffs are expected to begin in February, according to reports.
Pharma Giant Merck Sharp & Dohme Could Bring 600 New Jobs to Austin
Proteros biostructures GmbH Forges $167 Million+ Cancer R&D Deal With Merck Sharp & Dohme
Pharmaron LLC And Merck Sharp & Dohme Agree Deal To Acquire MSD’s UK Hoddesdon Site
Merck Sharp & Dohme Accused Of Failing To Produce 1,800 Documents In Propecia Case
Merck Sharp & Dohme to Present New Data at the 49th European Association for the Study of Diabetes Annual Meeting
European Commission (EC) Gives Green Light to New 6-in-1 Childhood Vaccine From Sanofi Pasteur
Asia Recalls Merck Sharp & Dohme's Contraceptive Devices
Merck Sharp & Dohme to Cut 280 Jobs in Wicklow, Plans to Cease Operations by 2015
Merck & Co., Inc. Release: ISENTRESS® (raltegravir) in Combination Therapy Demonstrated Long-Term Efficacy and Safety in Adult Patients Co-Infected With HIV-1 and Hepatitis B and/or C in a Subgroup Analysis at 240 Weeks
Merck Sharp & Dohme Reports Positive Data From Late Fertility Drug Trial
Merck Sharp & Dohme Opens New $21 Million Plant in Indonesia
90 Jobs to go at Merck Sharp & Dohme Plant in Cork